CORC  > 江苏大学
The constitutively active PKG II mutant effectively inhibits gastric cancer development via a blockade of EGF/EGFR associated signalling cascades
Wu, Yan[1]; Yuan, Miaomiao[2]; Su, Wenbin[3]; Zhu, Miaolin[4]; Yao, Xiaoyuan[5]; Wang, Ying[6]; Qian, Hai[7]; Jiang, Lu[8]; Tao, Yan[9]; Wu, Min[10]
刊名THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
2018
卷号10页码:1758834017751635
关键词epidermal growth factor epidermal growth factor receptor gastric cancer PKG II signalling cascades
ISSN号1758-8340
DOIhttp://dx.doi.org/10.1177/1758834017751635
URL标识查看原文
收录类别SCI(E) ; PUBMED
WOS记录号WOS:000429010600001
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/5338329
专题江苏大学
作者单位1.[1]Jiangsu Univ, Sch Med, Dept Physiol, 301 Xuefu Rd, Zhenjiang 212013, Jiangsu, Peoples R China.
2.Jiangsu Univ, Affiliated Hosp 4, Cent Lab, Zhenjiang 212013, Jiangsu, Peoples R China.
3.[2]Jiangsu Univ, Dept Physiol, Zhenjiang, Peoples R China.
4.[3]Jiangsu Univ, Dept Physiol, Zhenjiang, Peoples R China.
5.[4]Jiangsu Canc Hosp, Dept Pathol, Nanjing, Jiangsu, Peoples R China.
6.[5]Changchun Med Coll, Dept Basic Med, Changchun, Jilin, Peoples R China.
7.[6]Jiangsu Univ, Dept Physiol, Zhenjiang, Peoples R China.
8.[7]Jiangsu Univ, Dept Physiol, Zhenjiang, Peoples R China.
9.[8]Jiangsu Univ, Dept Physiol, Zhenjiang, Peoples R China.
10.[9]Jiangsu Univ, Dept Physiol, Zhenjiang, Peoples R China.
推荐引用方式
GB/T 7714
Wu, Yan[1],Yuan, Miaomiao[2],Su, Wenbin[3],et al. The constitutively active PKG II mutant effectively inhibits gastric cancer development via a blockade of EGF/EGFR associated signalling cascades[J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY,2018,10:1758834017751635.
APA Wu, Yan[1].,Yuan, Miaomiao[2].,Su, Wenbin[3].,Zhu, Miaolin[4].,Yao, Xiaoyuan[5].,...&Chen, Yongchang[12].(2018).The constitutively active PKG II mutant effectively inhibits gastric cancer development via a blockade of EGF/EGFR associated signalling cascades.THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY,10,1758834017751635.
MLA Wu, Yan[1],et al."The constitutively active PKG II mutant effectively inhibits gastric cancer development via a blockade of EGF/EGFR associated signalling cascades".THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY 10(2018):1758834017751635.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace